Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice

Psychopharmacology

Volumn 177, Issue 3, 2005, Pages 256-263

  Wu, Jinhua ^a   Zou, Hong ^a   Strong, Judith A ^b   Yu, Jun ^a   Zhou, Xuedong ^a   Xie, Qinglian ^a   Zhao, Guoping ^a   Jin, Meilei ^a   Yu, Lei ^b  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Dizocilpine maleate; Locomotion; NMDA receptor antagonist; Stereotypic movement disorder

Indexed keywords

AMPHETAMINE; DIZOCILPINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AUTOMATION; CONTROLLED STUDY; DNA MODIFICATION; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; LOCOMOTION; LOW DRUG DOSE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; STEREOTYPY; STIMULUS RESPONSE; TIME;

ANIMALS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; PSYCHOPHARMACOLOGY; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOTYPED BEHAVIOR; TIME FACTORS;

EID: 12344266784     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1944-1     Document Type: Article

References (30)

1. Adriani W, Felici A, Sargolini F, Roullet P, Usiello A, Oliverio A, Mele A (1998) N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes. Exp Brain Res 123:52-59
2. Amador M, Dani JA (1991) MK-801 inhibition of nicotinic acetylcholine receptor channels. Synapse 7:207-215
3. Cabib S, Puglisi-Allegra S, Oliverio A (1984) Chronic stress enhances apomorphine-induced stereotyped behavior in mice: involvement of endogenous opioids. Brain Res 298:138-140
4. Carlsson M, Carlsson A (1989) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75:221-226
5. Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neuro Sci 13:272-276
6. Carlsson A, Waters N, Carlsson ML (1999) Neurotransmitter interactions in schizophrenia - therapeutic implications. Biol Psychiatry 46:1388-1395
7. Clineschmidt BV, Martin GE, Bunting PR, Papp NL (1982) Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro- 5H-dibenzo [D]cyclohepten-5, 10-immine(MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Dev Res 2:135-145
8. Deutsch SI, Rosse RB, Mastropaolo J (1997) Behavioral approaches to the functional assessment of NMDA-mediated neural transmission in intact mice. Clin Neuropharmacol 20:375-384
9. Florin S, Suaudeau C, Meunier JC, Costentin J (1997) Orphan neuropeptide NocII, a putative pronociceptin maturation product, stimulates locomotion in mice. Neuroreport 8:705-707
10. Geter-Douglass B, Witkin JM (1999) Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice. Psychopharmacology 146:280-289
11. Harkin A, Morris K, Kelly JP, O'Donnell JM, Leonard BE (2001) Modulation of MK-801-induced behaviour by noradrenergic agents in mice. Psychopharmacology 154:177-188
12. Institute of Laboratory Animal Resources (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington
13. Javitt DC (1987) Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psychiatry 9:12-35
14. Kaplan GB, Greenblatt DJ, Kent MA, Cotreau MM, Arcelin G, Shader RI (1992) Caffeine-induced behavioral stimulation is dose-dependent and associated with A1 adenosine receptor occupancy. Neuropsychopharmacology 6:145-153
15. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20:379-382
16. Koyuncuoglu H, Kara I, Gunel MA, Nurten A, Yamanturk P (1998) N-methyl-D-aspartate antagonists, glutamate release inhibitors, 4-aminopyridine at neuromuscular transmission. Pharmacol Res 37:485-491
17. Lat J (1973) The analysis of habituation. Acta Neurobiol Exp 33:771-789
18. Liljequist S, Ossowska K, Grabowska-Anden M, Anden NE (1991) Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur J Pharmacol 195:55-61
19. Malomuzh AI, Mukhtarov MR, Urazaev AK, Nikol'skii EE, Vyskochil F (2002) The effects of glutamate on spontaneous acetylcholine secretion processes in the rat neuromuscular synapse. Neurosci Behav Physiol 32:577-582
20. Masuo Y, Noguchi J, Morita S, Matsumoto Y (1995) Effects of intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) on the motor activity and reserpine-induced hypothermia in murines. Brain Res 700:219-226
21. Miyamoto M, Narumi S, Nagai Y, Saji Y, Nagawa Y (1984) ATRH analog (DN-1417): motor stimulation with rearing related to catecholaminergic mechanisms in rats. Neuropharmacology 23:61-72
22. Moghaddam B (2003) Bringing order to the glutamate chaos in schizophrenia. Neuron 40:881-884
23. O'Neill MF, Shaw G (1999) Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice. Psychopharmacology 145:237-250
24. Ramoa AS, Alkondon M, Aracava Y, Irons J, Lunt GG, Deshpande SS, Wonnacott S, Aronstam RS, Albuquerque EX (1990) The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J Pharmacol Exp Ther 254:71-82
25. Randrup A, Munkvad I (1974) Pharmacology and physiology of stereotyped behavior. J Psychiatr Res 11:1-10
26. Randrup A, Munkvad I (1975) Stereotyped behavior. Pharmacol Ther [B] 1:757-768
27. Rukoyatkina NI, Gorbunova LV, Gmiro VE, Lukomskaya NY (2003) The ability of new non-competitive glutamate receptor blockers to weaken motor disorders in animals. Neurosci Behav Physiol 33:273-278
28. Smoothy R, Berry MS (1985) Time course of the locomotor stimulant and depressant effects of a single low dose of ethanol in mice. Psychopharmacology 85:57-61
29. Tiedtke PI, Bischoff C, Schmidt WJ (1990) MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J Neural Transm Gen Sect 81:173-182
30. Young R, Darmani NA, Elder EL, Dumas D, Glennon RA (1997) Clobenzorex: evidence for amphetamine-like behavioral actions. Pharmacol Biochem Behav 56:311-316